企業プロフィール
NovoCure Limited 株価・ニュース・カタリスト
- ティッカー:
- NVCR
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Switzerland
株価パフォーマンス
16.76 USD (-1.99%)
終値
最終更新: 2026年8月24日
1.83B USD
時価総額
株価変動の要因
As of Aug 24, 2026, NVCR closed down 1.99% at $16.76. No new same-company headline was identified in the current news window.
企業概要
事業概要
NovoCure is a medical technology company focused on tumor treating fields, a non-invasive cancer treatment modality. Its business is centered on device-based oncology treatment rather than pharmaceuticals.
所在地とセクター分類
NovoCure is headquartered in Switzerland and listed on NASDAQ. It sits in oncology medtech rather than biotechnology.
ビジネスモデルの特徴
The company depends on adoption of tumor treating fields, reimbursement, and clinical workflow integration. Investors watch usage growth, market expansion, and the breadth of oncology indications.
バイオ業界での位置付け
NovoCure occupies a unique device-oncology niche within healthcare. It is not biotech, but it is highly relevant to cancer treatment innovation.
今後のカタリスト
- NovoCure’s catalysts are TTFields adoption, reimbursement, and continued execution across tumor types. The company’s stock usually responds when utilization broadens and evidence strengthens.
最近のニュース
- 01
- 02
- 03
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。